Expert committees for biosafety assessments

Introduction

Expert committees for biosafety assessments are specialised regulatory and scientific bodies responsible for evaluating the potential risks associated with biotechnology research, genetically modified organisms (GMOs), genetically engineered products and other biological innovations. Their primary purpose is to ensure that scientific activities do not create unacceptable risks to human health, animals, agriculture or the environment.

Biotechnology developments such as genetic engineering, gene editing, recombinant DNA technology and genetically modified crops offer significant benefits. However, they may also create concerns relating to ecological imbalance, unintended genetic changes, biodiversity loss and biological safety. Expert committees provide scientific guidance to regulatory authorities by examining research proposals, assessing experimental evidence and recommending appropriate safety measures.

Meaning and objectives of biosafety assessment committees

Biosafety assessment committees are multidisciplinary bodies consisting of scientists, environmental specialists, medical professionals, toxicologists and regulatory experts. They evaluate whether proposed biotechnology activities can be conducted safely under specified conditions.

Their major objectives include:

Identifying potential biological and environmental hazards.

Evaluating risks associated with genetically modified organisms.

Reviewing laboratory and field research proposals.

Assessing containment and monitoring requirements.

Recommending preventive and corrective measures.

Ensuring compliance with applicable biosafety regulations.

Protecting biodiversity, public health and environmental resources.

These committees help ensure that biotechnology development follows the precautionary principle and responsible scientific practices.

Legal framework in India

1. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986, provides the principal statutory foundation for regulating specified activities involving hazardous microorganisms and genetically engineered organisms.

Section 6 empowers the Central Government to make rules regulating environmentally hazardous activities. Section 25 provides the government's rule-making authority.

Under this framework, the Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989, establish the regulatory structure for relevant biotechnology activities.

2. Rules of 1989 and regulatory committees

The 1989 Rules establish several authorities responsible for biosafety oversight.

Institutional Biosafety Committee (IBSC): It operates at the institutional level and supervises relevant research involving hazardous microorganisms and genetically engineered materials. It reviews research proposals, laboratory safety arrangements and containment practices.

Review Committee on Genetic Manipulation (RCGM): Functioning under the Department of Biotechnology, it reviews specified research activities involving genetic manipulation and monitors applicable safety requirements.

Genetic Engineering Appraisal Committee (GEAC): Functioning under the Ministry of Environment, Forest and Climate Change, GEAC evaluates specified proposals involving large-scale use, environmental release and related activities concerning genetically engineered organisms.

State Biotechnology Coordination Committee (SBCC): It coordinates and monitors relevant activities at the state level and supports enforcement of biosafety requirements.

District Level Committee (DLC): It performs local-level monitoring and inspection functions under the applicable regulatory framework.

3. Biological Diversity Act, 2002

The Biological Diversity Act, 2002, as amended in 2023, provides a framework for biodiversity conservation, sustainable use of biological resources and fair and equitable sharing of benefits.

The National Biodiversity Authority and State Biodiversity Boards perform important functions under this legislation. Their responsibilities may become relevant where biotechnology research involves biological resources or associated traditional knowledge.

4. Indian Council of Medical Research guidelines

The ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017, provide ethical principles for biomedical research.

Where biotechnology research involves human participants, Ethics Committees must examine informed consent, participant safety, confidentiality and the risk-benefit relationship. Biosafety assessment and human research ethics review are related but separate regulatory responsibilities.

Functions of expert committees

1. Scientific risk identification

Expert committees identify possible hazards arising from genetic modifications, biological materials and experimental procedures. They examine the characteristics of the organism, the introduced genetic material and the intended application.

2. Environmental risk assessment

For genetically modified crops and other organisms proposed for environmental release, committees may examine:

Potential effects on non-target organisms.

Possibility of gene flow to related species.

Effects on soil microorganisms.

Biodiversity and ecological consequences.

Potential development of resistance in pests.

Long-term environmental monitoring requirements.

3. Laboratory safety and containment

Committees review laboratory infrastructure, personnel training, waste management and containment arrangements. Their objective is to reduce accidental exposure and prevent unauthorised release of biological materials.

4. Monitoring and compliance

Expert committees may recommend inspections, reporting requirements and post-approval monitoring. They also examine whether institutions are following approved research conditions.

Important case laws

1. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making. It recognised that courts and regulatory authorities dealing with complex scientific questions should rely on appropriate expert knowledge. This judgment strongly supports the need for multidisciplinary expert committees in biosafety assessments.

2. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle and polluter-pays principle as important components of Indian environmental law. The judgment is relevant because biosafety committees must consider potential environmental harm even where scientific uncertainty remains.

3. Narmada Bachao Andolan v. Union of India (2000)

The Supreme Court examined environmental concerns associated with a major development project and discussed the relationship between development and environmental protection. Its reasoning is relevant by analogy to the need for scientific evaluation before approving activities that may create significant environmental consequences.

4. Aruna Rodrigues v. Union of India (2012 onwards)

This litigation concerned genetically modified crops, particularly the regulatory approval process for GM mustard and other genetically modified organisms. The Supreme Court proceedings brought attention to biosafety testing, scientific transparency, regulatory independence and environmental risk assessment. The litigation should not be treated as establishing a final judicial prohibition on all genetically modified crops.

5. Animal Welfare Board of India v. A. Nagaraja (2014)

The Supreme Court emphasised animal welfare and the constitutional importance of preventing unnecessary suffering. Although the case did not concern biotechnology approval committees directly, its principles are relevant where biosafety assessments involve animal experimentation and animal welfare considerations.

Challenges faced by expert committees

Despite their importance, biosafety committees face several institutional and scientific challenges. These include limited technical resources, possible conflicts of interest, incomplete experimental evidence and uncertainty about long-term ecological effects.

Other difficulties include:

Lack of sufficient independent scientific expertise.

Delays in reviewing complex research proposals.

Limited public access to assessment reports.

Difficulties in monitoring approved activities.

Rapid technological developments that outpace existing regulations.

Coordination problems between central, state and institutional authorities.

Safeguards for effective biosafety assessment

An effective biosafety system requires independent expertise, transparent decision-making and continuous monitoring. Committee members should disclose conflicts of interest and base their recommendations on reliable scientific evidence.

Important safeguards include independent peer review, standardised risk-assessment procedures, public consultation where appropriate, periodic review of approvals and clear accountability for regulatory decisions.

Expert committees should also distinguish between laboratory research, contained trials and environmental release because each activity may involve different levels of risk and regulatory scrutiny.

Conclusion

Expert committees for biosafety assessments play an essential role in ensuring that biotechnology research and commercial applications remain scientifically responsible and environmentally safe. India's framework under the Environment (Protection) Act, 1986, and the 1989 Rules establishes a structured system involving IBSC, RCGM, GEAC, SBCC and DLC. Judicial decisions such as A.P. Pollution Control Board v. Prof. M.V. Nayudu and Vellore Citizens' Welfare Forum v. Union of India reinforce the importance of scientific expertise and precautionary environmental protection. Strengthening institutional independence, transparency and monitoring is necessary to maintain public confidence and promote responsible biotechnology development.